Endometrial cancer classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial cancer}} | {{Endometrial cancer}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}{{AE}}{{RAK}} | ||
==Overview== | ==Overview== |
Latest revision as of 18:41, 26 November 2018
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer classification On the Web |
American Roentgen Ray Society Images of Endometrial cancer classification |
Risk calculators and risk factors for Endometrial cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]
Overview
Endometrial cancer may be classified according to histology into either type I comprising 80% of endometrial cancers or type II accounting for around 20%.
Classification
Endometrial cancer may be classified according to histology into 2 types:[1]
Type | Histology | Prognosis | Pathogenesis | Prevalence |
---|---|---|---|---|
Type I | Endometroid (adenocarcinoma) | Favorable (estrogen-responsive) | • May arise from atypical hyperplasia • Linked to unopposed estrogen stimulation |
80% |
Type II | • Endometroid • Serous • Clear cell • Mucinous • Squamous • Mesonephric • Undifferentiated |
Typically bad prognosis | • Develops from atrophic endometrium • Not linked to hormonally driven pathogenesis |
15-20% |
References
- ↑ Bokhman JV (1983). "Two pathogenetic types of endometrial carcinoma". Gynecol Oncol. 15 (1): 10–7. PMID 6822361.